0001140361-22-015034.txt : 20220419 0001140361-22-015034.hdr.sgml : 20220419 20220419163046 ACCESSION NUMBER: 0001140361-22-015034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220415 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220419 DATE AS OF CHANGE: 20220419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 22835244 BUSINESS ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 140 58TH STREET, BUILDING A STREET 2: SUITE 2100 CITY: BROOKLYN STATE: NY ZIP: 11220 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ALROY INDUSTRIES INC DATE OF NAME CHANGE: 19850411 8-K 1 brhc10036518_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 15, 2022
Brooklyn ImmunoTherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-11460
 31-1103425
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
10355 Science Center Drive, Suite 150
    
San Diego, California
  
92121
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant’s telephone number, including area code: (212) 582-1199

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  
Trading symbol
  
Name of each exchange on which registered
Common Stock, par value $0.005 per share
   BTX
  
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934:
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 4.01. Changes in Registrant’s Certifying Accountant.
 
As previously reported:  on January 18, 2022, Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the “Company”) notified Marcum LLP (“Marcum”) that it would be dismissed as the Company’s independent registered public accounting firm effective after the completion of Marcum’s audit of the Company’s financial statements for the year ended December 31, 2021; and the Audit Committee of the Company’s Board of Directors (the “Board”) approved Marcum’s dismissal on January 18, 2022.   Marcum’s dismissal became effective on April 15, 2022.  All disclosures required by Item 4.01 of Form 8-K with respect to Marcum’s dismissal were previously reported in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 24, 2022 and no events have occurred since such date that would have required the filing of an amendment to such Form 8-K.
 
Also as previously reported:  on January 18, 2022, the Company notified Grant Thornton LLP (“Grant Thornton”) that the Audit Committee of the Board had selected Grant Thornton to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 and related interim periods.
 
Grant Thornton’s engagement became effective on April 18, 2022.
 
During the two years ended December 31, 2021 and from December 31, 2021 through the date of filing of this Current Report on Form 8-K, neither the Company nor anyone acting on its behalf has consulted Grant Thornton regarding either: (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s financial statements, and no written report or oral advice was provided to the Company by Grant Thornton that Grant Thornton concluded was an important factor considered by the Company in reaching a decision as to an accounting, auditing or financial reporting issue; or (ii) any matter that was either subject of a disagreement, as that term is defined in Item 304 (a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a “reportable event,” as that term is described in Item 304(a)(1)(v) of Regulation S-K.
 
The Company furnished Marcum with a copy of the disclosure contained in this Item 4.01 prior to filing this Current Report on Form 8-K with the SEC and requested that Marcum furnish it with a letter addressed to the SEC stating whether or not it agreed with the statements made by the Company in this Item 4.01 insofar as they relate to Marcum’s audit services and engagement as the Company’s independent registered public accounting firm. Marcum has furnished a letter addressed to the SEC dated April 19, 2022, a copy of which is attached hereto as Exhibit 16.1.
 
Item 9.01
Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
Number
  
Description
 
Marcum, LLP letter dated April 19, 2022.
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 
Brooklyn ImmunoTherapeutics, Inc.
   
Dated: April 19, 2022
By:
/s/ Howard J. Federoff
   
Howard J. Federoff
   
Chief Executive Officer and President


EX-16.1 2 brhc10036518_ex16-1.htm EXHIBIT 16.1
Exhibit 16.1

April 19, 2022

Securities and Exchange Commission
100 F Street, N.E.
Washington, DC  20549

Commissioners:

We have read the statements made by Brooklyn ImmunoTherapeutics, Inc. under Item 4.01 of its Form 8-K dated April 15, 2022. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Brooklyn ImmunoTherapeutics, Inc. contained therein.

Very truly yours,

/s/ Marcum llp

Marcum llp


 EX-101.SCH 3 btx-20220415.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 btx-20220415_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 btx-20220415_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Apr. 15, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 15, 2022
Entity Registrant Name Brooklyn ImmunoTherapeutics, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-11460
Entity Tax Identification Number 31-1103425
Entity Address, Address Line One 10355 Science Center Drive
Entity Address, Address Line Two Suite 150
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 212
Local Phone Number 582-1199
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000748592
Title of 12(b) Security Common Stock, par value $0.005 per share
Trading Symbol BTX
Security Exchange Name NASDAQ
XML 7 brhc10036518_8k_htm.xml IDEA: XBRL DOCUMENT 0000748592 2022-04-15 2022-04-15 false 0000748592 8-K 2022-04-15 Brooklyn ImmunoTherapeutics, Inc. DE 001-11460 31-1103425 10355 Science Center Drive Suite 150 San Diego CA 92121 212 582-1199 false false false false Common Stock, par value $0.005 per share BTX NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://brooklynitx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10036518_8k.htm brhc10036518_ex16-1.htm btx-20220415.xsd btx-20220415_lab.xml btx-20220415_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10036518_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10036518_8k.htm" ] }, "labelLink": { "local": [ "btx-20220415_lab.xml" ] }, "presentationLink": { "local": [ "btx-20220415_pre.xml" ] }, "schema": { "local": [ "btx-20220415.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "btx", "nsuri": "http://brooklynitx.com/20220415", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10036518_8k.htm", "contextRef": "c20220415to20220415", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://brooklynitx.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10036518_8k.htm", "contextRef": "c20220415to20220415", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://brooklynitx.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001140361-22-015034-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-015034-xbrl.zip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